These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 20524422)

  • 41. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular automata model for swelling-controlled drug release.
    Laaksonen H; Hirvonen J; Laaksonen T
    Int J Pharm; 2009 Oct; 380(1-2):25-32. PubMed ID: 19563871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined models for data from in vitro-in vivo correlation experiments.
    Jacobs T; Rossenu S; Dunne A; Molenberghs G; Straetemans R; Bijnens L
    J Biopharm Stat; 2008; 18(6):1197-211. PubMed ID: 18991117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Layer-by-layer assembly of multilayer films for controlled drug release.
    Choi D; Hong J
    Arch Pharm Res; 2014 Jan; 37(1):79-87. PubMed ID: 24277693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A quality by design approach for longitudinal quality attributes.
    Lebrun P; Giacoletti K; Scherder T; Rozet E; Boulanger B
    J Biopharm Stat; 2015; 25(2):247-59. PubMed ID: 25360720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of the probability of passing the USP dissolution test.
    Wang H
    J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling of dispersed-drug delivery from planar polymeric systems: optimizing analytical solutions.
    Helbling IM; Ibarra JC; Luna JA; Cabrera MI; Grau RJ
    Int J Pharm; 2010 Nov; 400(1-2):131-7. PubMed ID: 20816929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of controlled release formulations by means of ALRISE's ImSus(®) platform technology.
    Seemann H; Albayrak C; Rindler V
    J Control Release; 2010 Nov; 148(1):e16-7. PubMed ID: 21529597
    [No Abstract]   [Full Text] [Related]  

  • 49. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems.
    Peppas NA; Narasimhan B
    J Control Release; 2014 Sep; 190():75-81. PubMed ID: 24998939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.
    Martinez M; Rathbone M; Burgess D; Huynh M
    J Control Release; 2008 Jul; 129(2):79-87. PubMed ID: 18514351
    [No Abstract]   [Full Text] [Related]  

  • 51. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
    Novick S; Shen Y; Yang H; Peterson J; LeBlond D; Altan S
    J Biopharm Stat; 2015; 25(2):351-71. PubMed ID: 25357203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling of diffusion controlled drug delivery.
    Siepmann J; Siepmann F
    J Control Release; 2012 Jul; 161(2):351-62. PubMed ID: 22019555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid exploration of curing process design space for production of controlled-release pellets.
    Kristan K; Horvat M
    J Pharm Sci; 2012 Oct; 101(10):3924-35. PubMed ID: 22833184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications.
    Dejaegher B; Heyden YV
    J Pharm Biomed Anal; 2011 Sep; 56(2):141-58. PubMed ID: 21632194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous release and ADME processes of poorly water-soluble drugs: mathematical modeling.
    Grassi G; Hasa D; Voinovich D; Perissutti B; Dapas B; Farra R; Franceschinis E; Grassi M
    Mol Pharm; 2010 Oct; 7(5):1488-97. PubMed ID: 20681582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple-time-point dissolution specifications for a sampling acceptance plan.
    Chen JJ; Tsong Y
    J Biopharm Stat; 1997 May; 7(2):259-70. PubMed ID: 9136068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical modeling of drug delivery from torus-shaped single-layer devices.
    Helbling IM; Luna JA; Cabrera MI
    J Control Release; 2011 Feb; 149(3):258-63. PubMed ID: 20971140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling of drug release from polymeric delivery systems--a review.
    Kanjickal DG; Lopina ST
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):345-86. PubMed ID: 15717734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Modified release of psychoactive compounds].
    Schaiquevich P
    Vertex; 2006; 17(67):203-9. PubMed ID: 16847479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Release of selected amino acids from zinc carriers.
    Dyja R; Dolińska B; Ryszka F
    Acta Pharm; 2016 Jun; 66(2):269-77. PubMed ID: 27279069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.